Selumetinib Paediatric NF1 Japan study

Trial Identifier:	D1346C00013
Sponsor:	AstraZeneca
NCTID::	NCT04495127
Start Date:	August 2020
Primary Completion Date:	June 2021
Study Completion Date:	March 2023

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

Language	Description
	English Version
	Japanese Translation

Stay informed about new Trial Results Summaries with our email notification service

Trial Locations

Country	Location
JP	Minato-ku, JP, 105-8471
JP	Nagoya-shi, JP, 466-8560
JP	Setagaya-ku, JP, 157-8535

Pharma Intelligence UK Limited is a company registered in England and Wales with company number 13787459 whose registered office is 3 More London Riverside, London SE1 2AQ.